Key result
COVID-19 pneumonia was associated with significant prolongation of QRS (87 vs. 78, p<.00) and QTc (429 vs. 400, p<.00) compared to controls.
Why the study?
Little was known about the role of ECG markers of increased risk of sudden cardiac death during the acute period of COVID-19 pneumonia.
Does COVID-19 pneumonia alter ECG markers of sudden cardiac death compared to controls?
Cross-Sectional (n=109)
Does COVID-19 pneumonia alter ECG markers of sudden cardiac death compared to controls?
Absolute Event Rate: 87% vs 78%
p-value: p=<.00
Patients with COVID-19 pneumonia exhibit significant changes in repolarization and conduction parameters, though those with mild to severe disease may be at low risk for torsades de pointes.
ECG changes in COVID-19 pneumonia merit monitoring caution; leaves open prospective validation of arrhythmic risk.
BACKGROUND: Little is known about the role of ECG markers of increased risk of sudden cardiac death during the acute period of coronavirus disease 2019 ( COVID-19) pneumonia. OBJECTIVES: To evaluate ECG markers of sudden cardiac death on admission, including the index of cardiac electrophysiological balance (iCEB) (QTc/QRS) and transmural dispersion of repolarization (TDR) (T from peak to end (Tp-e) interval and Tp-e/QTc), in patients with COVID-19 pneumonia. PATIENTS AND METHODS: This cross-sectional study included 63 patients with newly diagnosed COVID-19 pneumonia who presented to the outpatient clinic or admitted to the respiratory care unit between August 20 and September 15, 2020. Forty-six persons matched for sex and age were selected from data collected before COVID-19 pandemic. RESULTS: QRS and QTc showed a significant prolongation in patients with COVID-19 pneumonia compared to the controls (87 vs. 78, p < .00, and 429 versus. 400, p < .00, respectively). After categorization of patients with COVID-19 pneumonia into 3 groups according to the severity of pneumonia as mild-moderate, severe, and critical groups, a decreased values of QRS were observed in the critical COVID-19 pneumonia group compared to severe and mild-moderate COVID-19 pneumonia groups (p = .04) while increased values of QTc and iCEB(QTc/QRS) were noted in critical COVID-19 pneumonia group compared to other 2 groups(p < .00). CONCLUSIONS: Patients with COVID-19 pneumonia showed significant changes in repolarization and conduction parameters compared to controls. Patients with mild to severe COVID-19 pneumonia may be at low risk for torsades de pointes development.
No takes yet. Share an insight, caveat, or question.
Alareedh et al. (2021) conducted a cross-sectional in COVID-19 pneumonia (n=109). COVID-19 pneumonia vs. Age- and sex-matched controls was evaluated on QRS duration (p=<.00). COVID-19 pneumonia was associated with significant prolongation of QRS (87 vs. 78, p<.00) and QTc (429 vs. 400, p<.00) compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: